Does the media refer more to FTLF or DYAI?

In the previous week, FitLife Brands and FitLife Brands both had 3 articles in the media. FitLife Brands' average media sentiment score of 1.89 beat Dyadic International's score of 0.78 indicating that FitLife Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FitLife Brands 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Dyadic International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DYAI or VRCA?

In the previous week, Dyadic International and Dyadic International both had 3 articles in the media. Verrica Pharmaceuticals' average media sentiment score of 0.96 beat Dyadic International's score of 0.78 indicating that Verrica Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dyadic International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Verrica Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to DYAI or QTTB?

In the previous week, Q32 Bio had 8 more articles in the media than Dyadic International. MarketBeat recorded 11 mentions for Q32 Bio and 3 mentions for Dyadic International. Dyadic International's average media sentiment score of 0.78 beat Q32 Bio's score of 0.73 indicating that Dyadic International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dyadic International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Q32 Bio 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Dyadic International (DYAI) Competitors

$0.77 +0.06 (+8.31%)

As of 01:08 PM Eastern

Compare

DYAI vs. PEPG, FTLF, VRCA, CGTX, and QTTB

Should you buy Dyadic International stock or one of its competitors? MarketBeat compares Dyadic International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Dyadic International include PepGen (PEPG), FitLife Brands (FTLF), Verrica Pharmaceuticals (VRCA), Cognition Therapeutics (CGTX), and Q32 Bio (QTTB). These companies are all part of the "pharmaceutical products" industry.

How does Dyadic International compare to PepGen?

Dyadic International (NASDAQ:DYAI) and PepGen (NASDAQ:PEPG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

In the previous week, Dyadic International had 1 more articles in the media than PepGen. MarketBeat recorded 3 mentions for Dyadic International and 2 mentions for PepGen. Dyadic International's average media sentiment score of 0.78 beat PepGen's score of 0.44 indicating that Dyadic International is being referred to more favorably in the media.

Company	Overall Sentiment
Dyadic International	Positive
PepGen	Neutral

Dyadic International currently has a consensus price target of $3.00, suggesting a potential upside of 290.12%. PepGen has a consensus price target of $11.60, suggesting a potential upside of 665.68%. Given PepGen's stronger consensus rating and higher probable upside, analysts plainly believe PepGen is more favorable than Dyadic International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dyadic International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
PepGen	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

28.0% of Dyadic International shares are held by institutional investors. Comparatively, 58.0% of PepGen shares are held by institutional investors. 20.9% of Dyadic International shares are held by insiders. Comparatively, 1.3% of PepGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Dyadic International has higher revenue and earnings than PepGen. Dyadic International is trading at a lower price-to-earnings ratio than PepGen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dyadic International	$3.09M	9.07	-$7.36M	-$0.23	N/A
PepGen	N/A	N/A	-$89.65M	-$1.75	N/A

Dyadic International has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, PepGen has a beta of 2.01, suggesting that its share price is 101% more volatile than the broader market.

PepGen has a net margin of 0.00% compared to Dyadic International's net margin of -192.40%. PepGen's return on equity of -59.89% beat Dyadic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dyadic International	-192.40%	-1,005.45%	-77.64%
PepGen	N/A	-59.89%	-49.62%

Summary

PepGen beats Dyadic International on 9 of the 15 factors compared between the two stocks.

How does Dyadic International compare to FitLife Brands?

FitLife Brands (NASDAQ:FTLF) and Dyadic International (NASDAQ:DYAI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

FitLife Brands has higher revenue and earnings than Dyadic International. Dyadic International is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.20	$6.33M	$0.60	17.36
Dyadic International	$3.09M	9.07	-$7.36M	-$0.23	N/A

In the previous week, FitLife Brands and FitLife Brands both had 3 articles in the media. FitLife Brands' average media sentiment score of 1.89 beat Dyadic International's score of 0.78 indicating that FitLife Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Dyadic International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 28.0% of Dyadic International shares are held by institutional investors. 61.4% of FitLife Brands shares are held by company insiders. Comparatively, 20.9% of Dyadic International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

FitLife Brands has a net margin of 6.64% compared to Dyadic International's net margin of -192.40%. FitLife Brands' return on equity of 18.31% beat Dyadic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	6.64%	18.31%	8.21%
Dyadic International	-192.40%	-1,005.45%	-77.64%

FitLife Brands presently has a consensus target price of $21.50, suggesting a potential upside of 106.43%. Dyadic International has a consensus target price of $3.00, suggesting a potential upside of 290.12%. Given Dyadic International's stronger consensus rating and higher possible upside, analysts plainly believe Dyadic International is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Dyadic International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

FitLife Brands has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market. Comparatively, Dyadic International has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

Summary

FitLife Brands beats Dyadic International on 9 of the 14 factors compared between the two stocks.

How does Dyadic International compare to Verrica Pharmaceuticals?

Dyadic International (NASDAQ:DYAI) and Verrica Pharmaceuticals (NASDAQ:VRCA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

28.0% of Dyadic International shares are owned by institutional investors. Comparatively, 42.5% of Verrica Pharmaceuticals shares are owned by institutional investors. 20.9% of Dyadic International shares are owned by company insiders. Comparatively, 54.0% of Verrica Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Dyadic International and Dyadic International both had 3 articles in the media. Verrica Pharmaceuticals' average media sentiment score of 0.96 beat Dyadic International's score of 0.78 indicating that Verrica Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dyadic International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Verrica Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Dyadic International has higher earnings, but lower revenue than Verrica Pharmaceuticals. Verrica Pharmaceuticals is trading at a lower price-to-earnings ratio than Dyadic International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dyadic International	$3.09M	9.07	-$7.36M	-$0.23	N/A
Verrica Pharmaceuticals	$35.58M	2.88	-$17.89M	-$1.03	N/A

Dyadic International presently has a consensus price target of $3.00, indicating a potential upside of 290.12%. Verrica Pharmaceuticals has a consensus price target of $14.50, indicating a potential upside of 143.29%. Given Dyadic International's stronger consensus rating and higher possible upside, equities analysts clearly believe Dyadic International is more favorable than Verrica Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dyadic International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Verrica Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Verrica Pharmaceuticals has a net margin of -47.97% compared to Dyadic International's net margin of -192.40%. Dyadic International's return on equity of -1,005.45% beat Verrica Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dyadic International	-192.40%	-1,005.45%	-77.64%
Verrica Pharmaceuticals	-47.97%	-1,077.78%	-40.76%

Dyadic International has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Verrica Pharmaceuticals has a beta of 1.54, suggesting that its share price is 54% more volatile than the broader market.

Summary

Dyadic International and Verrica Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks.

How does Dyadic International compare to Cognition Therapeutics?

Cognition Therapeutics (NASDAQ:CGTX) and Dyadic International (NASDAQ:DYAI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

43.4% of Cognition Therapeutics shares are held by institutional investors. Comparatively, 28.0% of Dyadic International shares are held by institutional investors. 14.4% of Cognition Therapeutics shares are held by insiders. Comparatively, 20.9% of Dyadic International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Dyadic International had 2 more articles in the media than Cognition Therapeutics. MarketBeat recorded 3 mentions for Dyadic International and 1 mentions for Cognition Therapeutics. Dyadic International's average media sentiment score of 0.78 beat Cognition Therapeutics' score of 0.78 indicating that Dyadic International is being referred to more favorably in the news media.

Company	Overall Sentiment
Cognition Therapeutics	Positive
Dyadic International	Positive

Cognition Therapeutics currently has a consensus target price of $3.33, indicating a potential upside of 178.94%. Dyadic International has a consensus target price of $3.00, indicating a potential upside of 290.12%. Given Dyadic International's higher probable upside, analysts plainly believe Dyadic International is more favorable than Cognition Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cognition Therapeutics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Dyadic International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Dyadic International has higher revenue and earnings than Cognition Therapeutics. Cognition Therapeutics is trading at a lower price-to-earnings ratio than Dyadic International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cognition Therapeutics	N/A	N/A	-$23.49M	-$0.24	N/A
Dyadic International	$3.09M	9.07	-$7.36M	-$0.23	N/A

Cognition Therapeutics has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market. Comparatively, Dyadic International has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Cognition Therapeutics has a net margin of 0.00% compared to Dyadic International's net margin of -192.40%. Cognition Therapeutics' return on equity of -72.68% beat Dyadic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cognition Therapeutics	N/A	-72.68%	-53.07%
Dyadic International	-192.40%	-1,005.45%	-77.64%

Summary

Dyadic International beats Cognition Therapeutics on 8 of the 15 factors compared between the two stocks.

How does Dyadic International compare to Q32 Bio?

Dyadic International (NASDAQ:DYAI) and Q32 Bio (NASDAQ:QTTB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Q32 Bio has higher revenue and earnings than Dyadic International. Dyadic International is trading at a lower price-to-earnings ratio than Q32 Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dyadic International	$3.09M	9.07	-$7.36M	-$0.23	N/A
Q32 Bio	$53.74M	3.38	$29.82M	$2.66	4.03

In the previous week, Q32 Bio had 8 more articles in the media than Dyadic International. MarketBeat recorded 11 mentions for Q32 Bio and 3 mentions for Dyadic International. Dyadic International's average media sentiment score of 0.78 beat Q32 Bio's score of 0.73 indicating that Dyadic International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dyadic International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Q32 Bio	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Dyadic International currently has a consensus price target of $3.00, suggesting a potential upside of 290.12%. Q32 Bio has a consensus price target of $13.50, suggesting a potential upside of 25.92%. Given Dyadic International's higher probable upside, analysts clearly believe Dyadic International is more favorable than Q32 Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dyadic International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Q32 Bio	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

28.0% of Dyadic International shares are owned by institutional investors. Comparatively, 31.3% of Q32 Bio shares are owned by institutional investors. 20.9% of Dyadic International shares are owned by company insiders. Comparatively, 40.0% of Q32 Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Q32 Bio has a net margin of 0.00% compared to Dyadic International's net margin of -192.40%. Q32 Bio's return on equity of 149.23% beat Dyadic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dyadic International	-192.40%	-1,005.45%	-77.64%
Q32 Bio	N/A	149.23%	34.50%

Dyadic International has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market. Comparatively, Q32 Bio has a beta of -0.05, suggesting that its stock price is 105% less volatile than the broader market.

Summary

Q32 Bio beats Dyadic International on 12 of the 16 factors compared between the two stocks.

Get Dyadic International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DYAI vs. The Competition

Export

Metric	Dyadic International	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$28.02M	$3.40B	$6.42B	$12.60B
Dividend Yield	N/A	2.28%	2.75%	5.26%
P/E Ratio	-3.34	18.93	21.28	26.32
Price / Sales	9.07	333.54	558.91	114.49
Price / Cash	N/A	125.26	43.49	56.90
Price / Book	-76.90	7.29	10.60	7.34
Net Income	-$7.36M	$24.20M	$3.56B	$337.06M
7 Day Performance	1.29%	4.37%	3.21%	3.67%
1 Month Performance	1.49%	9.71%	6.51%	7.41%
1 Year Performance	-25.70%	63.73%	36.74%	37.93%

Dyadic International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DYAI Dyadic International	2.2065 of 5 stars	$0.77 +8.3%	$3.00 +290.1%	-29.4%	$28.02M	$3.09M	N/A	7	Gap Up High Trading Volume
PEPG PepGen	2.8172 of 5 stars	$1.38 -6.1%	$11.60 +740.6%	-5.1%	$101.68M	N/A	N/A	30
FTLF FitLife Brands	4.6395 of 5 stars	$10.00 -7.6%	$21.50 +115.0%	-26.7%	$101.61M	$81.46M	16.56	20	News Coverage Positive News High Trading Volume
VRCA Verrica Pharmaceuticals	3.2746 of 5 stars	$5.59 -4.8%	$17.00 +204.1%	+11.7%	$100.84M	$35.58M	N/A	40	Analyst Forecast Gap Down
CGTX Cognition Therapeutics	3.7276 of 5 stars	$1.11 +1.8%	$3.33 +200.3%	+388.5%	$97.55M	N/A	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DYAI) was last updated on 5/29/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dyadic International (DYAI) Competitors

DYAI vs. PEPG, FTLF, VRCA, CGTX, and QTTB

How does Dyadic International compare to PepGen?

Summary

How does Dyadic International compare to FitLife Brands?

Summary

How does Dyadic International compare to Verrica Pharmaceuticals?

Summary

How does Dyadic International compare to Cognition Therapeutics?

Summary

How does Dyadic International compare to Q32 Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYAI vs. The Competition

Dyadic International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dyadic International (DYAI) Competitors

DYAI vs. PEPG, FTLF, VRCA, CGTX, and QTTB

How does Dyadic International compare to PepGen?

Does the media prefer DYAI or PEPG?

Do analysts recommend DYAI or PEPG?

Do insiders & institutionals believe in DYAI or PEPG?

Which has better earnings & valuation, DYAI or PEPG?

Which has more volatility & risk, DYAI or PEPG?

Is DYAI or PEPG more profitable?

Summary

How does Dyadic International compare to FitLife Brands?

Which has better valuation and earnings, FTLF or DYAI?

Does the media refer more to FTLF or DYAI?

Do insiders and institutionals believe in FTLF or DYAI?

Is FTLF or DYAI more profitable?

Do analysts rate FTLF or DYAI?

Which has more volatility & risk, FTLF or DYAI?

Summary

How does Dyadic International compare to Verrica Pharmaceuticals?

Do insiders and institutionals believe in DYAI or VRCA?

Does the media prefer DYAI or VRCA?

Which has better valuation & earnings, DYAI or VRCA?

Do analysts prefer DYAI or VRCA?

Is DYAI or VRCA more profitable?

Which has more volatility and risk, DYAI or VRCA?

Summary

How does Dyadic International compare to Cognition Therapeutics?

Do insiders & institutionals have more ownership in CGTX or DYAI?

Does the media favor CGTX or DYAI?

Do analysts recommend CGTX or DYAI?

Which has preferable valuation & earnings, CGTX or DYAI?

Which has more risk and volatility, CGTX or DYAI?

Is CGTX or DYAI more profitable?

Summary

How does Dyadic International compare to Q32 Bio?

Which has higher valuation & earnings, DYAI or QTTB?

Does the media refer more to DYAI or QTTB?

Do analysts recommend DYAI or QTTB?

Do insiders & institutionals hold more shares of DYAI or QTTB?

Is DYAI or QTTB more profitable?

Which has more volatility & risk, DYAI or QTTB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYAI vs. The Competition

Dyadic International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools